RxDoctor Payments Data

Barbara Corral

Family · Mentor, OHNPI 1235705278

Payments from drug & device makers

$596in general payments, 2019–2025

Across 33 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$159
  • Xeris Pharmaceuticals, Inc.$107
  • Novo Nordisk$104
  • Lilly USA, LLC$86
  • Boehringer Ingelheim$60
  • Amryt Pharma Holdings Ltd$34
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$596100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$596 in reported general payments places this provider in the 60th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$5,621
Medicare patients
39
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide146$211,469
TrulicityDulaglutide133$187,338
JardianceEmpagliflozin121$143,652
OzempicSemaglutide77$134,699
FarxigaDapagliflozin Propanediol11$16,305
Humalog Kwikpen U-100Insulin Lispro53$11,887
Fiasp FlextouchInsulin Aspart (Niacinamide)12$9,714
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog25$9,601
Lantus SolostarInsulin Glargine,hum.Rec.Anlog57$7,288
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/712$4,959
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic15$1,218
Levothyroxine Sodium54$639
Metformin Hcl ErMetformin Hcl42$453
Metformin Hcl33$307
Glipizide ErGlipizide34$244

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$86$398,807279 claims
Boehringer IngelheimJardiance$60$143,652121 claims
Novo NordiskOzempic$104$134,69977 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,812 family providers in Ohio.

Other family in Mentor

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →